4 ms·
There is a hospital in France using the Hydroxychloroquine + Azithromycin treatment on patients and publishing the ongoing numbers: https://www.mediterranee-in
by eric_b 7y ago
There is a hospital in France using the Hydroxychloroquine + Azithromycin treatment on patients and publishing the ongoing numbers:
https://www.mediterranee-infection.com/covid-19/ https://www.mediterranee-infection.com/covid-19/
They don't publish demographics that I could find, but certainly the fact that 1,283 people have been given that treatment and only 1 person that received it for at least three days has died, that strongly suggests it's better than "nothing".
- lbeltrame 7y agoIMO the impact of the drugs should be, more than preventing deaths, in reducing hospitalization or even prevent going into the ICU, which can mean removing load off the healthcare system and make infections manageable (far more than waiting out for a vaccine). In fact, some the remdesivir trials which will end next month (end of April) measure also the time spent in the hospital.